The DOI matches its Crossref record; 117 of the 117 references it cites were found in a registry or an index.
Proteoglycans in Atherosclerosis and Restenosis: Key Roles for Versican
Open accessAbstract
The proteoglycan versican is one of several extracellular matrix (ECM) molecules that accumulate in lesions of atherosclerosis and restenosis. Its unique structural features create a highly interactive molecule that binds growth factors, enzymes, lipoproteins, and a variety of other ECM components to influence fundamental events involved in vascular disease. Versican is one of the principal genes that is upregulated after vascular injury and is a prominent component in stented and nonstented restenotic lesions. The synthesis of versican is highly regulated by specific growth factors and cytokines and the principal source of versican is the smooth muscle cell. Versican interacts with hyaluronan, a long chain glycosaminoglycan, to create expanded viscoelastic pericellular matrices that are required for arterial smooth muscle cell (ASMC) proliferation and migration. Versican is also prominent in advanced lesions of atherosclerosis, at the borders of lipid-filled necrotic cores as well as at the plaque-thrombus interface, suggesting roles in lipid accumulation, inflammation, and thrombosis. Versican influences the assembly of ECM and controls elastic fiber fibrillogenesis, which is of fundamental importance in ECM remodeling during vascular disease. Collectively, these studies highlight the critical importance of this specific ECM component in atherosclerosis and restenosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Atherosclerosis--an inflammatory disease
Ross, R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901143400207 · Cited by 21,725
The Molecular and Cellular Biology of Wound Repair
(1988) · Springer eBooks · doi:10.1007/978-1-4615-1795-5 · Cited by 1,516
The Response-to-Retention Hypothesis of Early Atherogenesis
Williams, K. J., & Tabas, I. (1995) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.15.5.551 · Cited by 1,413
Subendothelial retention of atherogenic lipoproteins in early atherosclerosis
Skålén, K., Gustafsson, M., Rydberg, E. K., Hultén, L. M., Wiklund, O., Innerarity, T. L., & Borén, J. (2002) · Nature · doi:10.1038/nature00804 · Cited by 1,019
Physiological function of connective tissue polysaccharides.
Comper, W. D., & Laurent, T. C. (1978) · Physiological Reviews · doi:10.1152/physrev.1978.58.1.255 · Cited by 991
Elastin is an essential determinant of arterial morphogenesis
Li, D. Y., Brooke, B., Davis, E. C., Mecham, R. P., Sorensen, L. K., Boak, B. B., Eichwald, E., & Keating, M. T. (1998) · Nature · doi:10.1038/30522 · Cited by 790
Multiple domains of the large fibroblast proteoglycan, versican.
Zimmermann, D. R., & Ruoslahti, E. (1989) · The EMBO Journal · doi:10.1002/j.1460-2075.1989.tb08447.x · Cited by 652
Desforges, J. F., & Ernst, C. B. (1993) · New England Journal of Medicine · doi:10.1056/nejm199304223281607 · Cited by 576
Versican: a versatile extracellular matrix proteoglycan in cell biology
Wight, T. N. (2002) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(02)00375-7 · Cited by 562
Self-citationHyaluronan-Cell Interactions in Cancer and Vascular Disease
Toole, B. P., Wight, T. N., & Tammi, M. I. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.r100039200 · Cited by 491
Self-citation
Cited by
Roles of vascular oxidative stress and nitric oxide in the pathogenesis of atherosclerosis
Förstermann, U., Xia, N., & Li, H. (2017) · Circulation Research · doi:10.1161/circresaha.116.309326 · Cited by 1,519
Hyaluronan as an Immune Regulator in Human Diseases
Jiang, D., Liang, J., & Noble, P. W. (2011) · Physiological Reviews · doi:10.1152/physrev.00052.2009 · Cited by 1,060
The magic glue hyaluronan and its eraser hyaluronidase: A biological overview
Girish, K. S., & Kemparaju, K. (2007) · Life Sciences · doi:10.1016/j.lfs.2007.02.037 · Cited by 674
Extracellular Matrix Molecules: Potential Targets in Pharmacotherapy
Järveläinen, H., Sainio, A., Koulu, M., Wight, T. N., & Penttinen, R. (2009) · Pharmacological Reviews · doi:10.1124/pr.109.001289 · Cited by 566
Self-citationEndogenous ligands of TLR2 and TLR4: agonists or assistants?
Erridge, C. (2010) · Journal of Leukocyte Biology · doi:10.1189/jlb.1209775 · Cited by 518
Metadata
- Authors
- Wight, T. N., & Merrilees, M. J.
- Venue
- Circulation Research
- Published
- 2004-05-14
- Volume
- 94
- Issue
- 9
- Pages
- 1158-1167
- ISSN
- 0009-7330 (ISSN-L)
- 1524-4571
- OpenAlex
- W2138063219
- Cited by
- 362
- References
- 117
- FWCI
- 6.29
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Proteoglycans in Atherosclerosis and Restenosis: Key Roles for Versican. https://app.cochat.ai/papers/10.1161/01.res.0000126921.29919.51
- The paper
- Wight, T. N., & Merrilees, M. J. (2004). Proteoglycans in Atherosclerosis and Restenosis: Key Roles for Versican. Circulation Research. https://doi.org/10.1161/01.res.0000126921.29919.51
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.